NO954186L - Plaster med aktive bestanddeler - Google Patents

Plaster med aktive bestanddeler

Info

Publication number: NO954186L
Authority: NO; Norway
Prior art keywords: patch; active ingredients; vitamin; deriv; contg
Prior art date: 1993-04-20

Application number

NO954186A

Other languages

English (en)

Other versions

NO954186D0 (no

NO311829B1 (no

Inventor

Wilfried Fischer

Karin Klokkers

Original Assignee

Hexal Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-20

Filing date

1995-10-19

Publication date

1995-10-19

1993-11-18 Priority claimed from DE19934339400 external-priority patent/DE4339400A1/de

1995-10-19 Application filed by Hexal Ag filed Critical Hexal Ag

1995-10-19 Publication of NO954186L publication Critical patent/NO954186L/no

1995-10-19 Publication of NO954186D0 publication Critical patent/NO954186D0/no

2002-02-04 Publication of NO311829B1 publication Critical patent/NO311829B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)
Laminated Bodies (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO19954186A 1993-04-20 1995-10-19 Plaster med virksomt stoff, i form av et laminat NO311829B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE4312818		1993-04-20
DE19934339400 DE4339400A1 (de)	1993-11-18	1993-11-18	Wirkstoffpflaster
PCT/EP1994/001231 WO1994023707A1 (de)	1993-04-20	1994-04-20	Wirkstoffplaster

Publications (3)

Publication Number	Publication Date
NO954186L true NO954186L (no)	1995-10-19
NO954186D0 NO954186D0 (no)	1995-10-19
NO311829B1 NO311829B1 (no)	2002-02-04

Family

ID=25925074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19954186A NO311829B1 (no)	1993-04-20	1995-10-19	Plaster med virksomt stoff, i form av et laminat

Country Status (14)

Country	Link
US (2)	US5683711A (no)
EP (2)	EP0695177B1 (no)
JP (1)	JP3489831B2 (no)
AT (2)	ATE205706T1 (no)
AU (1)	AU678237B2 (no)
CA (1)	CA2161004C (no)
DE (2)	DE59405277D1 (no)
DK (2)	DK0695177T3 (no)
ES (2)	ES2164286T3 (no)
FI (1)	FI114782B (no)
HU (2)	HU223045B1 (no)
NO (1)	NO311829B1 (no)
PT (1)	PT813865E (no)
WO (1)	WO1994023707A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4429667C2 (de) *	1994-08-20	1996-07-11	Lohmann Therapie Syst Lts	Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19517145C2 (de) *	1995-05-10	2000-02-24	Hexal Pharmaforschung Gmbh	Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
NZ309980A (en)	1995-06-07	2001-06-29	Noven Pharma	Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
US6316022B1 (en) *	1995-06-07	2001-11-13	Noven Pharmaceuticals, Inc.	Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19533089C1 (de)	1995-09-07	1997-05-22	Hexal Ag	Tacrin-Pflaster
DE19642043A1 (de) *	1995-10-23	1997-04-24	Hexal Ag	Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht
DE19548332A1 (de) *	1995-12-22	1997-07-10	Rotta Res Bv	Hormonpflaster
US5968547A (en) *	1997-02-24	1999-10-19	Euro-Celtique, S.A.	Method of providing sustained analgesia with buprenorphine
US20020012694A1 (en) *	1997-09-17	2002-01-31	Alfred J. Moo-Young	Transdermal administration of ment
US6767902B2 (en)	1997-09-17	2004-07-27	The Population Council, Inc.	Androgen as a male contraceptive and non-contraceptive androgen replacement
WO1999026571A1 (en)	1997-11-25	1999-06-03	Theratech, Inc.	Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
DE19814257A1 (de)	1998-03-31	1999-10-07	Asta Medica Ag	Brauseformulierungen
DE19828273B4 (de) *	1998-06-25	2005-02-24	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US6475514B1 (en)	1998-12-03	2002-11-05	Andrew Blitzer	Athletic patch
DE19859910C2 (de) *	1998-12-23	2001-03-22	Ratiopharm Gmbh	Orales Arzneimittel
NZ512599A (en)	1998-12-30	2003-10-31	Dexcel Ltd	Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
US6417227B1 (en)	1999-04-28	2002-07-09	Cg And Associates	Methods of delivery of cetyl myristoleate
US6358939B1 (en)	1999-12-21	2002-03-19	Northern Lights Pharmaceuticals, Llc	Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en)	1999-12-21	2006-01-24	Wisconsin Alumni Research Foundation	Treating vitamin D responsive diseases
US7732404B2 (en)	1999-12-30	2010-06-08	Dexcel Ltd	Pro-nanodispersion for the delivery of cyclosporin
US7235397B1 (en)	2000-04-14	2007-06-26	Gensys, Inc.	Methods and compositions for culturing spirochete and treating spirochetal diseases
DE10053397A1 (de) *	2000-10-20	2002-05-02	Schering Ag	Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) *	2000-08-24	2007-08-09	Neurobiotec Gmbh	Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
US20020119187A1 (en) *	2000-09-29	2002-08-29	Cantor Adam S.	Composition for the transdermal delivery of fentanyl
WO2002054996A2 (en) *	2000-10-23	2002-07-18	Euro Celtique Sa	Terazosin transdermal device and methods
DE10141651B4 (de) *	2001-08-24	2007-02-15	Lts Lohmann Therapie-Systeme Ag	Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10141650C1 (de)	2001-08-24	2002-11-28	Lohmann Therapie Syst Lts	Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) *	2001-08-24	2011-04-07	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
IL160551A0 (en) *	2001-09-04	2004-07-25	Trommsdorff Arzneimittel	Plaster for the treatment of dysfunctions and disorders of nails
CN100525767C (zh) *	2002-06-10	2009-08-12	欧洲凯尔特公司	防止所含活性剂被误用的经皮给药器的处置系统
AU2004210406B2 (en) *	2003-02-07	2008-10-09	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
CZ295826B6 (cs) *	2003-04-28	2005-11-16	Ústav Makromolekulární Chemie Av Čr	Materiál pro krytí ran obsahující lapače radikálů
ME00114B (me) *	2003-10-28	2011-02-10	Noven Pharma	Kompozicije i postupci za kontrolisanje gubitka i oslobađanja lijeka u transdermalnim sistemima oslobađanja lijeka
US20050096311A1 (en) *	2003-10-30	2005-05-05	Cns Response	Compositions and methods for treatment of nervous system disorders
DE102004059880A1 (de) *	2004-12-10	2006-06-14	Grünenthal GmbH	Stabiles, hormonhaltiges (Zwischen-)Produkt
JP5084496B2 (ja) *	2005-02-04	2012-11-28	久光製薬株式会社	経皮吸収貼付剤
US20070018059A1 (en) *	2005-07-25	2007-01-25	Woodcock John E	Apparatus for holding a container at an angle
PT2120896T (pt) *	2007-01-11	2017-08-30	Drossapharm Ag	Adesivo medicamente ativo
US8513323B2 (en) *	2007-06-22	2013-08-20	Kimbery-Clark Worldwide, Inc.	Multifunctional silicone blends
EP2640389B1 (en)	2010-11-17	2014-12-31	Hexal AG	Transdermal therapeutic system comprising buprenorphine
WO2014159798A1 (en)	2013-03-13	2014-10-02	Avery Dennison Corporation	Improving adhesive properties

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7711916A (nl) *	1977-10-29	1979-05-02	Akzo Nv	Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
US4439432A (en) *	1982-03-22	1984-03-27	Peat Raymond F	Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS59184121A (ja) *	1983-03-31	1984-10-19	Nitto Electric Ind Co Ltd	アクリル系膏体
US5023084A (en) *	1986-12-29	1991-06-11	Rutgers, The State University Of New Jersey	Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (no) *	1987-04-02	1990-06-29	Ciba Geigy Ag
US5300291A (en) *	1988-03-04	1994-04-05	Noven Pharmaceuticals, Inc.	Method and device for the release of drugs to the skin
GB8807504D0 (en) *	1988-03-29	1988-05-05	Sandoz Ltd	Improvements in/relating to organic compounds
JP2857882B2 (ja) *	1988-11-02	1999-02-17	富山化学工業株式会社	ピロキシカムのプラスター剤
DE3902013A1 (de) *	1989-01-25	1990-09-20	Knoll Ag	Pflaster zur transdermalen anwendung
JP2875611B2 (ja) *	1990-08-29	1999-03-31	エーザイ株式会社	ケイ酸カルシウム含有外用剤
GB9021674D0 (en) *	1990-10-05	1990-11-21	Ethical Pharma Ltd	Transdermal device
DE4116912A1 (de) *	1991-05-18	1992-11-26	Schering Ag	Mittel zur transdermalen applikation enthaltend ergolin-derivate
JP2671248B2 (ja) *	1991-10-23	1997-10-29	ブロック・ドラッグ・カンパニー・インコーポレイテッド	薬効または化粧効果成分の浸透性増進方法
DE4237453C1 (no) *	1992-11-06	1993-08-19	Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De

1994
- 1994-04-20 CA CA002161004A patent/CA2161004C/en not_active Expired - Fee Related
- 1994-04-20 AU AU65696/94A patent/AU678237B2/en not_active Expired
- 1994-04-20 PT PT97113342T patent/PT813865E/pt unknown
- 1994-04-20 DE DE59405277T patent/DE59405277D1/de not_active Expired - Lifetime
- 1994-04-20 AT AT97113342T patent/ATE205706T1/de active
- 1994-04-20 DK DK94913616T patent/DK0695177T3/da active
- 1994-04-20 HU HU9502994A patent/HU223045B1/hu active IP Right Revival
- 1994-04-20 JP JP52278494A patent/JP3489831B2/ja not_active Expired - Fee Related
- 1994-04-20 ES ES97113342T patent/ES2164286T3/es not_active Expired - Lifetime
- 1994-04-20 EP EP94913616A patent/EP0695177B1/de not_active Expired - Lifetime
- 1994-04-20 WO PCT/EP1994/001231 patent/WO1994023707A1/de not_active Ceased
- 1994-04-20 DE DE59409873T patent/DE59409873D1/de not_active Expired - Lifetime
- 1994-04-20 US US08/535,038 patent/US5683711A/en not_active Expired - Lifetime
- 1994-04-20 HU HU0301253A patent/HU223042B1/hu active IP Right Grant
- 1994-04-20 DK DK97113342T patent/DK0813865T3/da active
- 1994-04-20 AT AT94913616T patent/ATE163262T1/de active
- 1994-04-20 ES ES94913616T patent/ES2115231T3/es not_active Expired - Lifetime
- 1994-04-20 EP EP97113342A patent/EP0813865B1/de not_active Expired - Lifetime
1995
- 1995-10-19 FI FI954989A patent/FI114782B/fi not_active IP Right Cessation
- 1995-10-19 NO NO19954186A patent/NO311829B1/no not_active IP Right Cessation
1997
- 1997-04-01 US US08/829,858 patent/US5830505A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
HU0301253D0 (en)	2003-07-28
FI114782B (fi)	2004-12-31
EP0695177B1 (de)	1998-02-18
EP0695177A1 (de)	1996-02-07
HUT73668A (en)	1996-09-30
WO1994023707A1 (de)	1994-10-27
ATE163262T1 (de)	1998-03-15
AU678237B2 (en)	1997-05-22
CA2161004A1 (en)	1994-10-27
US5830505A (en)	1998-11-03
JP3489831B2 (ja)	2004-01-26
EP0813865B1 (de)	2001-09-19
ATE205706T1 (de)	2001-10-15
FI954989L (fi)	1995-10-19
EP0813865A1 (de)	1997-12-29
HU223042B1 (hu)	2004-03-01
ES2164286T3 (es)	2002-02-16
ES2115231T3 (es)	1998-06-16
DE59405277D1 (de)	1998-03-26
US5683711A (en)	1997-11-04
DK0813865T3 (da)	2001-11-19
HU9502994D0 (en)	1995-12-28
NO954186D0 (no)	1995-10-19
AU6569694A (en)	1994-11-08
JPH09501398A (ja)	1997-02-10
FI954989A0 (fi)	1995-10-19
HU223045B1 (hu)	2004-03-01
DE59409873D1 (de)	2001-10-25
NO311829B1 (no)	2002-02-04
DK0695177T3 (da)	1998-09-28
CA2161004C (en)	2004-10-26
PT813865E (pt)	2002-02-28

Publication	Publication Date	Title
NO954186D0 (no)	1995-10-19	Plaster med aktive bestanddeler
NO900356D0 (no)	1990-01-25	Blandinger med forsinket frigjoering.
ATE154237T1 (de)	1997-06-15	Inhalationspulver enthaltend antistatisches hilfsmittel
FI955215A0 (fi)	1995-11-01	Hallitusti vapauttavat oksibutyniinivalmisteet
CY1106984T1 (el)	2012-09-26	Νεα βιοσυγκολλητικη συνθεση που περιεχει μια βιοσυγκολλητικη πολυφαινολικη πρωτεϊνη, ενα πολυμερες που περιεχει ομαδες υδατανθρακα, φαρμακευτικως αποδεκτα λεπτα νηματα και οι χρησεις τους
DE68917908D1 (de)	1994-10-06	4,4'-bis(methacryloylthio)diphenylsulfid und vernetzbare zusammensetzung daraus.
BR9306683A (pt)	1998-12-08	Adesivo proteináceo curado com aldeído
AU3619295A (en)	1996-05-02	Antiinflammatory agent for external use
GR890100838A (el)	1991-03-15	Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της.
FI904584A7 (fi)	1991-03-21	Aktiivinen matriisinestekidenäyttö
DE69619052D1 (de)	2002-03-21	Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
GR1000318B (el)	1992-06-25	Θεραπευτικως δραστικη υποκατεστημενη βενζιμιδαζολη και μεθοδος για την παρασκευη αυτης.
DE59709386D1 (de)	2003-04-03	Wirkstoffhaltige Pflaster
KR950701162A (ko)	1995-02-20	카르테시안 멀티 캐리어 피드백(cartesian multicarrier feedback)
GB2324091A (en)	1998-10-14	Metalloproteinase inhibitors
AU8121391A (en)	1992-01-30	Self-sticking matrix system for the sustained transcutaneous release of piribedil
ATE83668T1 (de)	1993-01-15	Pflaster zur transdermalen anwendung.
DK0579939T3 (da)	1999-09-20	Phospholipidderivater
EP0401262A4 (en)	1993-05-05	24r-scymnol, and preparation and use thereof
BR9901381A (pt)	2001-10-30	Composições para a cura de polìmero
BR9901387A (pt)	2000-03-28	Composições para a cura de polìmero.
ES2116399T3 (es)	1998-07-16	Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida.
MX9403275A (es)	1995-01-31	Metilendioxi[3,'4':6,7]indolizino-[1,2-b]quinolinonas substituidas.
BR9901390A (pt)	2001-03-20	Composições para a cura de polìmero
IT8622051A1 (it)	1988-04-17	Composizioni farmaceutiche ad attivita' cicatrizzante

Legal Events

Date	Code	Title	Description
2014-04-28	MK1K	Patent expired